TRPM7 deficiency exacerbates cardiovascular and renal damage induced by aldosterone-salt

Area of Science:

• Physiology
• Molecular Biology
• Cardiovascular Research

Background:

• Hyperaldosteronism is linked to cardiovascular disease and hypomagnesemia.
• The role of TRPM7 (a magnesium-permeable channel/kinase) in these conditions is not well understood.

Purpose of the Study:

• To investigate the function of TRPM7 in aldosterone-induced cardiovascular and renal injury.
• To explore the molecular mechanisms linking TRPM7, magnesium, and hyperaldosteronism.

Main Methods:

• Utilized TRPM7-deficient (TRPM7+/Δkinase) mice treated with aldosterone and salt.
• Measured plasma and tissue magnesium levels, TRPM7 phosphorylation, and markers of cardiovascular/renal damage.
• Analyzed gene expression of phosphatases and phosphorylation of key signaling proteins (Smad3, ERK1/2, Stat1).

Main Results:

• TRPM7 deficiency exacerbated aldosterone-induced hypertension, vascular dysfunction, and organ fibrosis.
• Reduced tissue magnesium and TRPM7 phosphorylation were observed in deficient mice.
• Aldosterone increased pro-fibrotic signaling in TRPM7-deficient fibroblasts, an effect reversed by magnesium supplementation.

Conclusions:

• TRPM7 downregulation and hypomagnesemia are implicated in the cardiovascular and renal damage caused by hyperaldosteronism.
• TRPM7 deficiency amplifies aldosterone-salt-induced cardiovascular remodeling.
• Magnesium supplementation shows potential for ameliorating hyperaldosteronism-related organ damage.